Literature DB >> 28943591

Anti-transcription Intermediary Factor1γ-antibody-positive Dermatomyositis Complicated by Dysphagia.

Shota Kurushima1, Yoshiro Horai1,2, Masataka Umeda1, Atsushi Kawakami1.   

Abstract

Entities:  

Keywords:  anti-transcription intermediary factor1γ-antibody; dermatomyositis; dysphagia

Year:  2017        PMID: 28943591      PMCID: PMC5709653          DOI: 10.2169/internalmedicine.9149-17

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


× No keyword cloud information.
A man who was aged in his 80s was hospitalized in our department because of Gottron's sign, muscle weakness and dysphagia. He was diagnosed with dermatomyositis (DM) based on the physical symptoms, muscle enzyme elevation and the results of electromyography. Immunoprecipitation for myositis-specific antibodies revealed bands of 140/155 kDa (Picture 1), which were compatible with anti-transcription intermediary factor-1γ (TIF-1γ)-antibody (1). Although we could not perform colonoscopy because the patient did not undergo pretreatment, no evidence of malignancy was found on computed tomography or esophagogastroduodenoscopy. Videofluoroscopy showed that liquid had entered the lungs and paste and porridge intrusion in the larynx (Picture 2). T2-weighted fat-saturated magnetic resonance imaging revealed an area of high signal intensity in the levator veli palatini muscle and lateral pterygoid (Picture 3), which was improved by prednisolone and tacrolimus. Although dysphagia persisted, even after the start of immunosuppressive treatment, it was gradually improved by rehabilitation. Mugii et al. reported that 10 of 13 patients DM with dysphagia were positive for anti-TIF-1γ-antibodies (2). We presented images of dysphagia related to anti-TIF-1γ-antibody-positive DM. Dysphagia should be noted as an important complication of anti-TIF-1γ-antibody-positive DM.
Picture 1.
Picture 2.
Picture 3.

The authors state that they have no Conflict of Interest (COI).
  2 in total

1.  Myositis-specific anti-155/140 autoantibodies target transcription intermediary factor 1 family proteins.

Authors:  Manabu Fujimoto; Yasuhito Hamaguchi; Kenzo Kaji; Takashi Matsushita; Yuki Ichimura; Masanari Kodera; Naoko Ishiguro; Ikuko Ueda-Hayakawa; Yoshihide Asano; Fumihide Ogawa; Keita Fujikawa; Takuya Miyagi; Eriko Mabuchi; Kenji Hirose; Narihiro Akimoto; Naohito Hatta; Kiyohiro Tsutsui; Akira Higashi; Atsuyuki Igarashi; Mariko Seishima; Minoru Hasegawa; Kazuhiko Takehara
Journal:  Arthritis Rheum       Date:  2012-02

2.  Oropharyngeal Dysphagia in Dermatomyositis: Associations with Clinical and Laboratory Features Including Autoantibodies.

Authors:  Naoki Mugii; Minoru Hasegawa; Takashi Matsushita; Yasuhito Hamaguchi; Sacihe Oohata; Hirokazu Okita; Tetsutarou Yahata; Fujiko Someya; Katsumi Inoue; Shigeyuki Murono; Manabu Fujimoto; Kazuhiko Takehara
Journal:  PLoS One       Date:  2016-05-11       Impact factor: 3.240

  2 in total
  1 in total

1.  Rare Features of Dermatomyositis in a Patient with Ovarian Cancer.

Authors:  Lissandra Dal Lago; Frédéric Vandergheynst; Ahmad Awada; Thierry Pepersack
Journal:  Eur J Case Rep Intern Med       Date:  2020-12-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.